Palbociclib Combine With Anti-HER2 Therapy in Triple Positive ABC
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Neoplasm Female
Interventions: DRUG: CDK4/6 inhibitor (Qilu),Trastuzumab (Hanquyou)
Sponsor: Peking University Cancer Hospital & Institute